Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

<p>Abstract</p> <p>Background</p> <p>The current standard treatment, at least in Europe, for patients with primarily resectable tumors, consists of surgery followed by adjuvant chemotherapy. But even in this prognostic favourable group, long term survival is disappointing because of high local and d...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Roeder Falk, Timke Carmen, Saleh-Ebrahimi Ladan, Schneider Lutz, Hackert Thilo, Hartwig Werner, Kopp-Schneider Annette, Hensley Frank W, Buechler Markus W, Debus Juergen, Huber Peter E, Werner Jens
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2012-03-01
סדרה:	BMC Cancer
גישה מקוונת:	http://www.biomedcentral.com/1471-2407/12/112
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!